Healthy Volunteers
Conditions
Interventions
Exercise load and placebo blood drawing
Exercise load and test food A (active ingredient 2.5mg) blood drawing
Exercise load and test food B (active ingredient 10mg) blood drawing
Exercise load a
Sponsors
Otsuka Pharmaceutical Co., Ltd.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1)Healthy subjects who are aged 20-64 2)Subjects whose maximal oxygen consumption (VO2peak) is 38 mL/kg min or less 3)Subjects who can participate in dietary interventions, intake of test foods, blood samplings, urine samplings, and maintain rest as scheduled 4)Subjects who voluntarily give written informed consent
Exclusion criteria
Exclusion criteria: 1)Subjects whose blood test results are judged to be ineligible for this study by lead principal investigator 2)Subjects with gastrointestinal, cardiovascular, endocrine, or other disorders, or with a history of such disorders, who are judged by lead principal investigator to be ineligible for the study 3)As a rule, subjects who regularly use drugs for the treatment of diseases 4)Subjects who are judged to be ineligible for this study by lead principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| oxygen utilization efficiency and maximal oxygen uptake | — |
Secondary
| Measure | Time frame |
|---|---|
| respiratory rate, ventilation threshold, exercise duration, blood concentration, and urinary excretion | — |
Countries
Japan
Contacts
Public ContactYasutaka Ikeda
Otsuka Pharmaceutical Co., Ltd. Saga Nutraceuticals Research Institute
Outcome results
None listed